vs
CODEXIS, INC.（CDXS）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是CODEXIS, INC.的1.8倍（$71.1M vs $38.9M），CODEXIS, INC.净利率更高（24.7% vs 2.0%，领先22.6%），CODEXIS, INC.同比增速更快（81.3% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $19.6M），过去两年CODEXIS, INC.的营收复合增速更高（51.0% vs -4.7%）
科迪西斯是一家专注于蛋白质工程的企业，核心业务是开发可应用于制药、食品及医疗领域的酶制剂，依托自身技术优势为相关行业提供高性能的生物催化解决方案，助力生命科学与食品加工领域的技术升级。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
CDXS vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.8倍
$38.9M
营收增速更快
CDXS
高出83.2%
-1.8%
净利率更高
CDXS
高出22.6%
2.0%
自由现金流更多
RMAX
多$13.9M
$19.6M
两年增速更快
CDXS
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.9M | $71.1M |
| 净利润 | $9.6M | $1.4M |
| 毛利率 | 94.8% | — |
| 营业利润率 | 27.1% | 13.1% |
| 净利率 | 24.7% | 2.0% |
| 营收同比 | 81.3% | -1.8% |
| 净利润同比 | 192.5% | -75.2% |
| 每股收益（稀释后） | $0.13 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDXSRMAX
| Q4 25 | $38.9M | $71.1M | ||
| Q3 25 | $8.6M | $73.2M | ||
| Q2 25 | $15.3M | $72.8M | ||
| Q1 25 | $7.5M | $74.5M | ||
| Q4 24 | $21.5M | $72.5M | ||
| Q3 24 | $12.8M | $78.5M | ||
| Q2 24 | $8.0M | $78.5M | ||
| Q1 24 | $17.1M | $78.3M |
净利润CDXSRMAX
| Q4 25 | $9.6M | $1.4M | ||
| Q3 25 | $-19.6M | $4.0M | ||
| Q2 25 | $-13.3M | $4.7M | ||
| Q1 25 | $-20.7M | $-2.0M | ||
| Q4 24 | $-10.4M | $5.8M | ||
| Q3 24 | $-20.6M | $966.0K | ||
| Q2 24 | $-22.8M | $3.7M | ||
| Q1 24 | $-11.5M | $-3.4M |
毛利率CDXSRMAX
| Q4 25 | 94.8% | — | ||
| Q3 25 | 71.3% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 63.8% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 66.4% | — | ||
| Q2 24 | 56.6% | — | ||
| Q1 24 | 71.6% | — |
营业利润率CDXSRMAX
| Q4 25 | 27.1% | 13.1% | ||
| Q3 25 | -220.3% | 25.0% | ||
| Q2 25 | -83.9% | 19.3% | ||
| Q1 25 | -271.6% | 7.2% | ||
| Q4 24 | -34.2% | 5.9% | ||
| Q3 24 | -129.0% | 19.4% | ||
| Q2 24 | -284.9% | 20.6% | ||
| Q1 24 | -69.6% | 5.8% |
净利率CDXSRMAX
| Q4 25 | 24.7% | 2.0% | ||
| Q3 25 | -228.1% | 5.4% | ||
| Q2 25 | -86.6% | 6.4% | ||
| Q1 25 | -274.3% | -2.6% | ||
| Q4 24 | -48.4% | 8.0% | ||
| Q3 24 | -160.8% | 1.2% | ||
| Q2 24 | -285.2% | 4.7% | ||
| Q1 24 | -67.4% | -4.3% |
每股收益（稀释后）CDXSRMAX
| Q4 25 | $0.13 | — | ||
| Q3 25 | $-0.22 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.29 | — | ||
| Q2 24 | $-0.32 | — | ||
| Q1 24 | $-0.16 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.2M | $118.7M |
| 总债务越低越好 | $40.1M | $432.2M |
| 股东权益账面价值 | $50.5M | $452.4M |
| 总资产 | $147.8M | $582.5M |
| 负债/权益比越低杠杆越低 | 0.79× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资CDXSRMAX
| Q4 25 | $78.2M | $118.7M | ||
| Q3 25 | $58.7M | $107.5M | ||
| Q2 25 | $66.3M | $94.3M | ||
| Q1 25 | $59.8M | $89.1M | ||
| Q4 24 | $73.5M | $96.6M | ||
| Q3 24 | $90.3M | $83.8M | ||
| Q2 24 | $73.2M | $66.1M | ||
| Q1 24 | $85.5M | $82.1M |
总债务CDXSRMAX
| Q4 25 | $40.1M | $432.2M | ||
| Q3 25 | $39.7M | $433.3M | ||
| Q2 25 | $39.4M | $434.4M | ||
| Q1 25 | $29.2M | $435.3M | ||
| Q4 24 | $28.9M | $436.2M | ||
| Q3 24 | $28.6M | $437.2M | ||
| Q2 24 | $28.4M | $438.1M | ||
| Q1 24 | $28.1M | $439.0M |
股东权益CDXSRMAX
| Q4 25 | $50.5M | $452.4M | ||
| Q3 25 | $38.5M | $448.1M | ||
| Q2 25 | $55.6M | $442.4M | ||
| Q1 25 | $49.6M | $433.5M | ||
| Q4 24 | $66.9M | $429.5M | ||
| Q3 24 | $73.4M | $423.1M | ||
| Q2 24 | $61.4M | $418.4M | ||
| Q1 24 | $79.3M | $412.0M |
总资产CDXSRMAX
| Q4 25 | $147.8M | $582.5M | ||
| Q3 25 | $124.0M | $582.2M | ||
| Q2 25 | $138.2M | $574.8M | ||
| Q1 25 | $128.9M | $571.4M | ||
| Q4 24 | $149.0M | $581.6M | ||
| Q3 24 | $148.2M | $578.6M | ||
| Q2 24 | $132.0M | $571.4M | ||
| Q1 24 | $149.6M | $566.7M |
负债/权益比CDXSRMAX
| Q4 25 | 0.79× | 0.96× | ||
| Q3 25 | 1.03× | 0.97× | ||
| Q2 25 | 0.71× | 0.98× | ||
| Q1 25 | 0.59× | 1.00× | ||
| Q4 24 | 0.43× | 1.02× | ||
| Q3 24 | 0.39× | 1.03× | ||
| Q2 24 | 0.46× | 1.05× | ||
| Q1 24 | 0.35× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.1M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $19.6M | $33.5M |
| 自由现金流率自由现金流/营收 | 50.3% | 47.1% |
| 资本支出强度资本支出/营收 | 1.3% | 10.4% |
| 现金转化率经营现金流/净利润 | 2.09× | 28.39× |
| 过去12个月自由现金流最近4个季度 | $-23.8M | $56.8M |
8季度趋势，按日历期对齐
经营现金流CDXSRMAX
| Q4 25 | $20.1M | $40.9M | ||
| Q3 25 | $-7.7M | $17.7M | ||
| Q2 25 | $-18.0M | $4.6M | ||
| Q1 25 | $-13.8M | $5.7M | ||
| Q4 24 | $-16.5M | $59.7M | ||
| Q3 24 | $-13.0M | $17.6M | ||
| Q2 24 | $-12.2M | $15.9M | ||
| Q1 24 | $-7.8M | $9.4M |
自由现金流CDXSRMAX
| Q4 25 | $19.6M | $33.5M | ||
| Q3 25 | $-7.9M | $16.4M | ||
| Q2 25 | $-20.5M | $2.9M | ||
| Q1 25 | $-15.1M | $4.0M | ||
| Q4 24 | $-18.2M | $53.0M | ||
| Q3 24 | $-14.0M | $16.3M | ||
| Q2 24 | $-12.6M | $14.0M | ||
| Q1 24 | $-8.9M | $6.8M |
自由现金流率CDXSRMAX
| Q4 25 | 50.3% | 47.1% | ||
| Q3 25 | -91.7% | 22.4% | ||
| Q2 25 | -133.6% | 4.0% | ||
| Q1 25 | -199.6% | 5.3% | ||
| Q4 24 | -85.0% | 73.2% | ||
| Q3 24 | -109.0% | 20.8% | ||
| Q2 24 | -157.5% | 17.8% | ||
| Q1 24 | -52.2% | 8.6% |
资本支出强度CDXSRMAX
| Q4 25 | 1.3% | 10.4% | ||
| Q3 25 | 2.1% | 1.8% | ||
| Q2 25 | 16.4% | 2.2% | ||
| Q1 25 | 16.7% | 2.3% | ||
| Q4 24 | 8.3% | 9.1% | ||
| Q3 24 | 7.8% | 1.7% | ||
| Q2 24 | 5.0% | 2.4% | ||
| Q1 24 | 6.6% | 3.3% |
现金转化率CDXSRMAX
| Q4 25 | 2.09× | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDXS
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
